Publication | Closed Access

The effect of bezafibrate on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition in Type 1 diabetes associated with hypercholesterolaemia or combined hyperlipidaemia

ObesityType 1Intermediate Density LipoproteinBody CompositionCardiovascular DiseaseDiabetesPhysiologyHyperlipidemiaLipoprotein MetabolismDiabetes MellitusMedicineAtherosclerosisDyslipidemiaLow Density LipoproteinHealth Sciences